To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MED26_TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
688 representative clones for gene MED26_ back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CN336425 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1 to 698 1 to 697   tiling clone,   697/697
(100 %)
3 diff
(99.6 %id)
NM_006387.5   .a 1 to 4095 1 to 4095 exact RefSeq, AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 4095/4095
(100 %)
0 diff
(100 %id)
BX401755   .a 3 to 1000 1 to 998       998/998
(100 %)
9 diff
(99.1 %id)
BX442566 brain, fetal brain .a 7 to 1046 1 to 1032       1032/1032
(100 %)
22 diff
(97.9 %id)
BQ929572 leiomyosarcoma, uterus .a 8 to 917 6 to 920       915/920
(99 %)
19 diff
(98.0 %id)
CD557301 testis .a 10 to 756 1 to 748       748/924
(80 %)
17 diff
(98.2 %id)
BM545482 brain, hippocampus .a 11 to 861 1 to 866   tiling clone,   866/996
(86 %)
24 diff
(97.6 %id)
TI_57235399   .a 14 to 802 25 to 815       791/818
(96 %)
19 diff
(97.7 %id)
BC021294 Uterus, leiomyosarcoma .a 16 to 4085 1 to 4070   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 4070/4070
(100 %)
2 diff
(100.0 %id)
BX342824   .a 16 to 1119 1 to 1089       1089/1092
(99 %)
22 diff
(98.0 %id)
CF993915 Human Placenta, placenta .a 16 to 669 28 to 676       649/725
(89 %)
16 diff
(97.8 %id)
CF593296 Human Placenta, placenta .a 16 to 861 29 to 882       854/965
(88 %)
32 diff
(96.7 %id)
BI908372 leukocyte .a 21 to 802 1 to 784       784/787
(99 %)
9 diff
(98.9 %id)
BI600877 brain, hypothalamus .a 21 to 924 1 to 898       812/901
(90 %)
24 diff
(97.4 %id)
CN336428 embryonic stem cells, cell lines H1, H7, andH9 .a 22 to 680 1 to 660       660/660
(100 %)
2 diff
(99.7 %id)
BI826176 brain, medulla .a 24 to 689 1 to 669       669/669
(100 %)
4 diff
(99.5 %id)
BI917191 brain .a 24 to 634 1 to 611       611/611
(100 %)
4 diff
(99.4 %id)
BM923150 leukocyte .a 24 to 1077 19 to 1082       1064/1084
(98 %)
39 diff
(96.5 %id)
TI_57242252   .a 24 to 634 37 to 647       611/647
(94 %)
4 diff
(99.4 %id)
BU521129 leiomyosarcoma, uterus .a 25 to 835 1 to 818       818/846
(96 %)
13 diff
(98.5 %id)
CX164861 human embryonic stem cells differentiated toan early endodermal cell type .a 26 to 876 1 to 851       851/851
(100 %)
2 diff
(99.8 %id)
DB460486.
matches multiple genes
testis .a 27 to 508 1 to 482     also hits gene C19orf44 482/482
(100 %)
0 diff
(100 %id)
TI_45214155   .a 27 to 927 132 to 1026       895/1026
(87 %)
79 diff
(92.4 %id)
BM472162 embryonal carcinoma, cell line, testis .a 29 to 876 30 to 880       851/1043
(81 %)
21 diff
(98.0 %id)
BX353991 Neuroblastoma Cot 25-normalized .a 30 to 950 1 to 922       922/922
(100 %)
9 diff
(99.1 %id)
BI917192 brain .a 31 to 635 1 to 606       606/606
(100 %)
6 diff
(99.1 %id)
TI_57170674   .a 31 to 816 63 to 847       785/847
(92 %)
17 diff
(98.0 %id)
BX354966 Neuroblastoma Cot 25-normalized .a 32 to 941 1 to 902       902/902
(100 %)
13 diff
(98.6 %id)
BM903581 ovary (pool of 3) .a 32 to 974 5 to 949       945/1031
(91 %)
11 diff
(99.0 %id)
TI_57239216   .a 33 to 857 29 to 847       819/850
(96 %)
18 diff
(97.9 %id)
AF536542   .a 34 to 4088 1 to 4055       4055/4061
(99 %)
9 diff
(99.8 %id)
BI915489 brain .a 34 to 857 1 to 818       818/821
(99 %)
8 diff
(99.1 %id)
CT002991 T-Lymphocytes .a 34 to 757 1 to 724       724/724
(100 %)
0 diff
(100 %id)
TI_154162178   .a 34 to 754 82 to 794       713/729
(97 %)
21 diff
(97.2 %id)
BX442387 brain, fetal brain .a 35 to 1010 1 to 972       975/1004
(97 %)
27 diff
(97.4 %id)
BI825613 brain, medulla .a 36 to 816 1 to 780       780/780
(100 %)
11 diff
(98.6 %id)
DR158514 human embryonic stem cells differentiated toan early endodermal cell type .a 36 to 837 1 to 802       802/802
(100 %)
2 diff
(99.8 %id)
AL514754 neuroblastoma, placenta .a 37 to 582 1 to 546       546/546
(100 %)
0 diff
(100 %id)
CN336433 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 37 to 679 1 to 642       642/642
(100 %)
1 diff
(99.9 %id)
BU186591 embryonal carcinoma, cell line, testis .a 37 to 749 1 to 727       727/895
(81 %)
19 diff
(97.9 %id)
CN336426 embryonic stem cells, cell lines H1, H7, andH9 .a 40 to 790 1 to 752       752/752
(100 %)
4 diff
(99.5 %id)
BX331460 Neuroblastoma Cot 10-normalized .a 40 to 1063 1 to 1016       1016/1016
(100 %)
11 diff
(99.0 %id)
BX374529 Neuroblastoma Cot 10-normalized .a 40 to 1094 1 to 1051       1051/1135
(92 %)
10 diff
(99.2 %id)
TI_57235525   .a 40 to 816 38 to 812       775/812
(95 %)
11 diff
(98.7 %id)
BI826541 brain, medulla .a 41 to 688 1 to 648       648/648
(100 %)
2 diff
(99.7 %id)
BI908154 leukocyte .a 41 to 816 1 to 774       774/774
(100 %)
5 diff
(99.4 %id)
CB959869 Human Placenta, placenta .a 41 to 809 28 to 799       772/806
(95 %)
12 diff
(98.6 %id)
CB961050 Human Placenta, placenta .a 41 to 790 28 to 780       753/787
(95 %)
11 diff
(98.7 %id)
CB989723 Human Placenta, placenta .a 41 to 690 28 to 684       657/842
(78 %)
16 diff
(98.1 %id)
CF593909 Human Placenta, placenta .a 41 to 755 29 to 755       727/849
(85 %)
23 diff
(97.3 %id)
BI520279 brain, medulla .a 42 to 916 1 to 869       871/908
(95 %)
39 diff
(95.8 %id)
TI_43963150   .a 42 to 916 35 to 903       871/942
(92 %)
39 diff
(95.9 %id)
CN336427 embryonic stem cells, DMSO-treated H9 cellline .a 43 to 784 8 to 749       742/749
(99 %)
7 diff
(99.1 %id)
BC001552 Cervix, carcinoma .a 43 to 1762 1 to 1720   available from MGC,   1720/1720
(100 %)
3 diff
(99.9 %id)
BU197386 eye, retinoblastoma .a 43 to 862 1 to 825       825/830
(99 %)
13 diff
(98.5 %id)
Y08265   .a 44 to 1894 1 to 1852       1852/1852
(100 %)
8 diff
(99.6 %id)
BX394143 Neuroblastoma Cot 25-normalized .a 46 to 1050 1 to 996       996/1003
(99 %)
23 diff
(97.8 %id)
BX419323 brain, fetal brain .a 52 to 915 1 to 864       864/864
(100 %)
4 diff
(99.6 %id)
BI763944 pooled colon, kidney, stomach .a 52 to 951 1 to 900       900/966
(93 %)
16 diff
(98.4 %id)
BM548063 brain, hippocampus .a 52 to 1072 20 to 1061       1042/1105
(94 %)
31 diff
(97.2 %id)
TI_57151838   .a 52 to 951 59 to 958       900/1024
(87 %)
16 diff
(98.5 %id)
BQ425324 eye, retinoblastoma .a 58 to 808 8 to 764       757/878
(86 %)
28 diff
(96.9 %id)
CN336431 embryonic stem cells, cell lines H1, H7, andH9 .a 78 to 738 1 to 662       662/662
(100 %)
2 diff
(99.7 %id)
U94836   .a 99 to 4088 1 to 3990   tiling clone,   3990/3990
(100 %)
3 diff
(100.0 %id)
BI913443 brain .a 167 to 937 1 to 774       774/778
(99 %)
15 diff
(98.1 %id)
TI_57240482   .a 167 to 937 31 to 804       774/808
(95 %)
21 diff
(97.5 %id)
EL733563 mixed .a 171 to 807 1 to 637       637/637
(100 %)
1 diff
(99.9 %id)
TI_1948243897   .a 171 to 1200 124 to 1161       1038/1173
(88 %)
46 diff
(96.1 %id)
BM472553 embryonal carcinoma, cell line, testis .a 548 to 1307 1 to 780       780/1080
(72 %)
27 diff
(97.5 %id)
BX383087   .a 597 to 1458 1 to 861       861/861
(100 %)
12 diff
(98.7 %id)
BU501585 brain, neuroblastoma, cell line .a 610 to 1374 1 to 776       776/957
(81 %)
20 diff
(98.0 %id)
BI029115 marrow .a 711 to 1022 1 to 312       312/312
(100 %)
0 diff
(100 %id)
BX370684   .a 857 to 1767 1 to 910       910/916
(99 %)
15 diff
(98.4 %id)
BM811388 ovary (pool of 3) .a 885 to 1734 20 to 874       855/1112
(76 %)
28 diff
(97.5 %id)
AL514753 neuroblastoma, placenta .a 901 to 1774 874 to 1       874/874
(100 %)
3 diff
(99.7 %id)
CN336432 embryonic stem cells, cell lines H1, H7, andH9 .a 986 to 1596 1 to 611       611/611
(100 %)
1 diff
(99.9 %id)
CN336424 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 993 to 1686 1 to 695       695/695
(100 %)
3 diff
(99.6 %id)
CN336434 embryonic stem cells, cell lines H1, H7, andH9 .a 994 to 1369 1 to 376       376/376
(100 %)
0 diff
(100 %id)
G64277   .a 1014 to 1132 1 to 119       119/119
(100 %)
0 diff
(100 %id)
CN336437 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1027 to 1496 1 to 470       470/470
(100 %)
0 diff
(100 %id)
BQ069355 brain, neuroblastoma, cell line .a 1085 to 1910 1 to 839       839/1090
(76 %)
25 diff
(97.8 %id)
AL516980 brain, neuroblastoma, neuroblastoma cells .a 1124 to 1585 1 to 461       461/548
(84 %)
3 diff
(99.5 %id)
BQ711463 Spleen .a 1125 to 2003 18 to 903       886/987
(89 %)
24 diff
(97.6 %id)
AW978303   .a 1145 to 1770 633 to 7     Submitted on the opposite strand 627/634
(98 %)
5 diff
(99.3 %id)
BF205817 muscle, rhabdomyosarcoma .a 1206 to 1815 630 to 14     Submitted on the opposite strand 617/1193
(51 %)
16 diff
(98.7 %id)
AA836058 germinal center B cell .a 1245 to 1697 448 to 1       448/448
(100 %)
12 diff
(97.4 %id)
CR979201 T-Lymphocytes .a 1278 to 1762 1 to 485       485/485
(100 %)
0 diff
(100 %id)
BQ434588 leiomyosarcoma, uterus .a 1382 to 1762 1 to 381       381/381
(100 %)
0 diff
(100 %id)
AI500399 anaplastic oligodendroglioma, brain .a 1438 to 1747 310 to 1       310/310
(100 %)
0 diff
(100 %id)
DA597375   .a 1525 to 2023 2 to 500   capped   499/499
(100 %)
0 diff
(100 %id)
BI820034 pooled brain, lung, testis .a 1532 to 1762 1 to 231       231/231
(100 %)
0 diff
(100 %id)
CR994452 T-Lymphocytes .a 1578 to 1762 1 to 185       185/185
(100 %)
0 diff
(100 %id)
BE675623 B-cell, chronic lymphotic leukemia .a 1608 to 1749 142 to 1       142/142
(100 %)
0 diff
(100 %id)
BG056869 anaplastic oligodendroglioma, brain .a 1659 to 1755 97 to 1       97/97
(100 %)
0 diff
(100 %id)
BX479716   .a 1684 to 2275 1 to 592       592/593
(99 %)
1 diff
(99.9 %id)
BF926996 nervous_tumor .a 1694 to 1995 337 to 35     Submitted on the opposite strand 303/337
(89 %)
1 diff
(99.8 %id)
BY996371   .a 1723 to 2325 17 to 619       603/619
(97 %)
7 diff
(98.9 %id)
AW054861 anaplastic oligodendroglioma, brain .a 1763 to 2366 1 to 604     Submitted on the opposite strand 604/604
(100 %)
2 diff
(99.7 %id)
BE673277 Prostate .a 1763 to 2370 1 to 602     Submitted on the opposite strand 602/602
(100 %)
4 diff
(99.4 %id)
TI_154134385   .a 1763 to 2382 60 to 690     Submitted on the opposite strand 631/865
(72 %)
32 diff
(96.4 %id)
TI_154136599   .a 1763 to 2532 20 to 781     Submitted on the opposite strand 760/1110
(68 %)
28 diff
(97.5 %id)
BE465995 pooled germ cell tumors .a 1805 to 1934 13 to 142     Submitted on the opposite strand 130/142
(91 %)
6 diff
(95.8 %id)
TI_1948243898   .a 1864 to 2824 1085 to 126       960/1304
(73 %)
19 diff
(98.6 %id)
BM479101 melanotic melanoma, skin .a 1878 to 2631 1 to 755       755/1132
(66 %)
31 diff
(97.3 %id)
BM906399 ovary (pool of 3) .a 1928 to 2810 14 to 901       888/1065
(83 %)
17 diff
(98.5 %id)
CR602259 Neuroblastoma Cot 25-normalized .a 1935 to 4059 1 to 2125       2125/2125
(100 %)
0 diff
(100 %id)
AL528283 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 1935 to 3050 1 to 1107       1107/1115
(99 %)
21 diff
(98.2 %id)
TI_154140183   .a 1951 to 2419 550 to 82     Submitted on the opposite strand 469/474
(98 %)
11 diff
(97.7 %id)
BQ938072 leiomyosarcoma, uterus .a 1952 to 2856 12 to 921       910/930
(97 %)
31 diff
(96.7 %id)
AU119898 whole embryo, mainly head .a 1997 to 2805 2 to 811   capped   810/813
(99 %)
8 diff
(99.1 %id)
AW403483 lymph .a 2027 to 2419 404 to 12     Submitted on the opposite strand 393/404
(97 %)
8 diff
(98.1 %id)
BF338583 brain, glioblastoma with EGFR amplification .a 2040 to 2818 1 to 785       785/806
(97 %)
32 diff
(96.1 %id)
BU170657 eye, retinoblastoma .a 2041 to 2819 1 to 788       788/920
(85 %)
19 diff
(98.0 %id)
BG179784 adenocarcinoma, cell line, Prostate .a 2060 to 2767 707 to 3     Submitted on the opposite strand 705/964
(73 %)
4 diff
(99.6 %id)
AU124883   .a 2067 to 2813 2 to 747   capped   746/752
(99 %)
7 diff
(99.1 %id)
BG763378 melanotic melanoma, high MDR (cell line), skin .a 2074 to 2954 1 to 879       879/882
(99 %)
24 diff
(97.3 %id)
BU158176 epidermoid carcinoma, cell line, salivary gland .a 2087 to 2979 1 to 896       896/900
(99 %)
20 diff
(97.8 %id)
BQ669253 epidermoid carcinoma, cell line, salivary gland .a 2087 to 2994 1 to 915       915/934
(97 %)
65 diff
(93.1 %id)
BQ672002 epidermoid carcinoma, cell line, salivary gland .a 2087 to 2893 1 to 815       815/904
(90 %)
19 diff
(97.9 %id)
BG120907 adenocarcinoma, cell line, Liver .a 2150 to 2932 1 to 792       792/1189
(66 %)
33 diff
(97.3 %id)
BF345107 anaplastic oligodendroglioma with 1p/19qloss, brain .a 2166 to 2827 1 to 660       660/660
(100 %)
3 diff
(99.6 %id)
BE903191 choriocarcinoma, placenta .a 2197 to 2883 10 to 696       687/971
(70 %)
13 diff
(98.7 %id)
BE279395 choriocarcinoma, placenta .a 2216 to 2790 1 to 575       575/575
(100 %)
0 diff
(100 %id)
BE733964 choriocarcinoma, placenta .a 2216 to 2998 1 to 781       781/815
(95 %)
10 diff
(98.8 %id)
CD722667 eye, lacrimal gland .a 2269 to 2883 1 to 615       615/615
(100 %)
0 diff
(100 %id)
BQ676880 melanotic melanoma, cell line, skin .a 2271 to 3019 1 to 749       749/960
(78 %)
11 diff
(98.9 %id)
BX349957 Neuroblastoma Cot 25-normalized .a 2272 to 3101 830 to 1       830/893
(92 %)
13 diff
(98.6 %id)
BI254277 cervical carcinoma cell line, cervix .a 2275 to 3011 1 to 735       735/735
(100 %)
2 diff
(99.8 %id)
BG774166 choriocarcinoma, placenta .a 2288 to 3024 1 to 739       739/739
(100 %)
2 diff
(99.8 %id)
BE407683 choriocarcinoma, placenta .a 2307 to 3006 1 to 695       695/721
(96 %)
9 diff
(98.8 %id)
BF310854 brain, neuroblastoma .a 2365 to 3032 1 to 663       663/925
(71 %)
12 diff
(98.8 %id)
BF308461 muscle, rhabdomyosarcoma .a 2365 to 3137 1 to 763       763/911
(83 %)
25 diff
(97.3 %id)
BF306766 muscle, rhabdomyosarcoma .a 2365 to 3048 1 to 679       679/688
(98 %)
8 diff
(98.9 %id)
BE263576 lung, small cell carcinoma .a 2376 to 2928 1 to 553       553/553
(100 %)
0 diff
(100 %id)
Z46203 brain, total brain .a 2416 to 2743 1 to 328       328/328
(100 %)
0 diff
(100 %id)
BP198312 adrenal gland .a 2422 to 3003 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BE741277 adenocarcinoma cell line, ovary .a 2451 to 3181 1 to 731       731/731
(100 %)
2 diff
(99.8 %id)
BU839481 hepatocellular carcinoma, cell line, Liver .a 2460 to 3308 1 to 857       857/930
(92 %)
20 diff
(97.9 %id)
CA406146 adipose .a 2469 to 3036 1 to 568       568/568
(100 %)
0 diff
(100 %id)
BE792529 lung, small cell carcinoma .a 2796 to 3582 1 to 786       786/786
(100 %)
11 diff
(98.7 %id)
BE792536 lung, small cell carcinoma .a 2796 to 3595 1 to 796       796/856
(92 %)
11 diff
(98.8 %id)
CN336423 embryonic stem cells, cell lines H1, H7, andH9 .a 2833 to 3425 1 to 594       594/594
(100 %)
1 diff
(99.9 %id)
BG697834 skin .a 2865 to 3641 1 to 775       775/776
(99 %)
7 diff
(99.1 %id)
AL563109 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 2926 to 4059 1127 to 1       1127/1175
(95 %)
21 diff
(98.3 %id)
BG104518 adrenal cortex carcinoma, cell line, adrenal gland .a 2969 to 3797 1 to 825       825/1103
(74 %)
29 diff
(97.4 %id)
AW960797   .a 3009 to 3707 1 to 699       699/700
(99 %)
6 diff
(99.2 %id)
BY798357 eye .a 3121 to 3720 1 to 600       600/600
(100 %)
0 diff
(100 %id)
CB157547 Liver .a 3136 to 3688 1 to 553       553/553
(100 %)
0 diff
(100 %id)
BQ678854 melanotic melanoma, cell line, skin .a 3238 to 3998 1 to 763       763/908
(84 %)
17 diff
(98.2 %id)
BU157740 melanotic melanoma, cell line, skin .a 3238 to 3958 1 to 728       728/872
(83 %)
10 diff
(98.9 %id)
CB163182 Liver .a 3269 to 3928 1 to 660       660/660
(100 %)
0 diff
(100 %id)
TI_154055134   .a 3290 to 4091 870 to 86   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 785/967
(81 %)
20 diff
(98.0 %id)
BM717213 eye, lens .a 3298 to 3801 1 to 506   fully sequenced, Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 506/506
(100 %)
3 diff
(99.5 %id)
BQ000042 Fibrosarcoma .a 3301 to 4095 809 to 19   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 791/791
(100 %)
5 diff
(99.4 %id)
CA314222 Human Lung Epithelial cells, lung .a 3321 to 4037 735 to 19   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 717/717
(100 %)
3 diff
(99.6 %id)
TI_149315339   .a 3327 to 4091 854 to 101   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 754/938
(80 %)
17 diff
(98.2 %id)
TI_149293259   .a 3330 to 4085 833 to 89   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 745/947
(78 %)
23 diff
(97.6 %id)
CX758218 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 3341 to 4089 778 to 34   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 745/750
(99 %)
6 diff
(99.2 %id)
BM692273 eye, human retina .a 3359 to 3756 9 to 406   fully sequenced, Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 398/406
(98 %)
0 diff
(100 %id)
BM711737 eye, human retina .a 3359 to 3980 1 to 622       622/622
(100 %)
0 diff
(100 %id)
AA131669 uterus .a 3390 to 3682 1 to 294   fully sequenced,   294/294
(100 %)
0 diff
(100 %id)
BM849488 myeloma .a 3392 to 3926 1 to 535       535/535
(100 %)
0 diff
(100 %id)
CA426839 cell lines, Chondrosarcoma .a 3401 to 4089 705 to 15   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 691/691
(100 %)
3 diff
(99.6 %id)
CB241570 Human Lung Epithelial cells, lung .a 3411 to 4089 694 to 15   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 680/680
(100 %)
1 diff
(99.9 %id)
CA421967 Bone, Enchondroma cell line .a 3417 to 4089 691 to 19   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 673/673
(100 %)
0 diff
(100 %id)
TI_149292631   .a 3424 to 4091 750 to 83   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 668/718
(93 %)
15 diff
(98.0 %id)
AU146120 whole embryo, mainly head .a 3471 to 4085 612 to 1       612/612
(100 %)
5 diff
(99.2 %id)
BF526511 brain, glioblastoma with EGFR amplification .a 3487 to 4091 1 to 604       604/622
(97 %)
4 diff
(99.4 %id)
BU682502 lung .a 3490 to 4085 614 to 19   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 596/596
(100 %)
0 diff
(100 %id)
AU148663   .a 3545 to 4091 546 to 1       546/548
(99 %)
8 diff
(98.6 %id)
BE673120 Prostate .a 3591 to 4089 499 to 1       499/499
(100 %)
0 diff
(100 %id)
AI262272 adenocarcinoma, colon .a 3633 to 4091 459 to 1       459/459
(100 %)
0 diff
(100 %id)
EC509447 Prostate .a 3637 to 3741 1 to 105       105/105
(100 %)
0 diff
(100 %id)
AI091894 heart .a 3642 to 4089 448 to 1       448/448
(100 %)
0 diff
(100 %id)
AW129628 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 3647 to 4085 450 to 12   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 439/439
(100 %)
0 diff
(100 %id)
AA131738 uterus .a 3652 to 4085 441 to 1   fully sequenced,   441/441
(100 %)
2 diff
(99.6 %id)
AI024437   .a 3671 to 4085 432 to 18   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 415/415
(100 %)
0 diff
(100 %id)
AA195366 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3695 to 4092 403 to 2       402/406
(99 %)
0 diff
(100 %id)
AI348577 carcinoid, lung .a 3697 to 4094 398 to 1       398/398
(100 %)
0 diff
(100 %id)
BM673537 eye, human retina .a 3726 to 4089 379 to 16   fully sequenced, AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 364/364
(100 %)
0 diff
(100 %id)
AA887727 colon, colon tumor RER+ .a 3765 to 4095 331 to 1       331/331
(100 %)
0 diff
(100 %id)
BM669255 eye, lens .a 3771 to 4085 332 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 314/314
(100 %)
1 diff
(99.7 %id)
F05070 brain, total brain .a 3775 to 4085 311 to 1       311/311
(100 %)
1 diff
(99.7 %id)
AI685290 pooled .a 3786 to 4085 312 to 13   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 300/300
(100 %)
0 diff
(100 %id)
AW593867 pooled germ cell tumors .a 3800 to 4092 293 to 1       293/293
(100 %)
0 diff
(100 %id)
AA876246 pooled germ cell tumors .a 3871 to 4090 220 to 1       220/220
(100 %)
0 diff
(100 %id)
DB454265.
matches multiple genes
testis .b 1 to 297 1 to 297   tiling clone, also hits gene sinoru 297/297
(100 %)
4 diff
(98.7 %id)
DA695903   .b 162 to 689 2 to 529   capped   528/528
(100 %)
3 diff
(99.5 %id)
DB456857.
matches multiple genes
testis .b 163 to 647 1 to 485     also hits gene sinoru 485/485
(100 %)
1 diff
(99.8 %id)
CB993114 placenta, pre-eclamptic placenta .b 163 to 769 28 to 629       602/685
(87 %)
25 diff
(96.4 %id)
NM_004831.3   .b 163 to 3346 1 to 3184 exact RefSeq,   3184/3184
(100 %)
0 diff
(100 %id)
DA406833 thalamus .b 164 to 716 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DA495313 brain .b 164 to 451 2 to 289   capped   288/288
(100 %)
2 diff
(99.4 %id)
DB121973 thymus .b 164 to 718 2 to 559   capped   558/558
(100 %)
4 diff
(99.3 %id)
DB454875.
matches multiple genes
testis .b 165 to 656 1 to 492     also hits gene sinoru 492/492
(100 %)
1 diff
(99.8 %id)
DB460382 testis .b 165 to 620 1 to 456       456/456
(100 %)
0 diff
(100 %id)
DB498488 hypothalamus .b 165 to 684 1 to 520       520/520
(100 %)
1 diff
(99.9 %id)
DA769383 brain .b 172 to 755 2 to 587   capped   586/586
(100 %)
6 diff
(99.0 %id)
BM805851 ovary (pool of 3) .b 173 to 774 7 to 615       609/1162
(52 %)
36 diff
(97.0 %id)
BC110430 Uterus, leiomyosarcoma .b 182 to 3311 1 to 3130 R369L tiling clone, AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 3130/3130
(100 %)
1 diff
(100.0 %id)
BU146061 dorsal root ganglia .b 185 to 857 1 to 680       680/1019
(66 %)
23 diff
(97.8 %id)
AK313778 testis .b 191 to 2226 1 to 2036 D215G     2036/2036
(100 %)
1 diff
(100.0 %id)
BQ431826 leiomyosarcoma, uterus .b 192 to 716 1 to 528       528/992
(53 %)
32 diff
(96.8 %id)
DB075763 testis .b 192 to 665 2 to 476   capped   475/475
(100 %)
2 diff
(99.6 %id)
DB082897 testis .b 192 to 732 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
DB453814.
matches multiple genes
testis .b 204 to 698 1 to 495     also hits gene sinoru 495/495
(100 %)
0 diff
(100 %id)
DB452161.
matches multiple genes
testis .b 210 to 711 1 to 501     also hits gene sinoru 501/502
(99 %)
3 diff
(99.5 %id)
AF104253   .b 424 to 2226 1 to 1803 L156F     1803/1803
(100 %)
1 diff
(100.0 %id)
BE885087 leiomyosarcoma, uterus .b 468 to 1164 1 to 692       692/866
(79 %)
34 diff
(96.1 %id)
DA664534   .b 955 to 1644 2 to 692   capped   691/696
(99 %)
4 diff
(99.5 %id)
TI_57179906   .b 965 to 1812 27 to 876       850/876
(97 %)
7 diff
(99.3 %id)
BI770405 pooled lung and spleen .b 972 to 1812 1 to 843       843/843
(100 %)
2 diff
(99.8 %id)
BG760469 melanotic melanoma, high MDR (cell line), skin .b 990 to 1916 1 to 922       922/954
(96 %)
28 diff
(97.1 %id)
BG762432 melanotic melanoma, high MDR (cell line), skin .b 990 to 1865 1 to 886       886/906
(97 %)
34 diff
(96.3 %id)
CO249884 Chondrosarcoma Lung Metastasis cell lines, lung .b 1057 to 1727 7 to 672       666/798
(83 %)
6 diff
(99.3 %id)
BP269543 thyroid .b 1235 to 1818 1 to 584       584/584
(100 %)
0 diff
(100 %id)
DA616843   .b 1249 to 1821 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DB033204 testis .b 1257 to 1832 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
CR603051 Placenta Cot 25-normalized .b 1330 to 3273 1 to 1944   tiling clone,   1944/1944
(100 %)
0 diff
(100 %id)
AL549211 placenta, Placenta Cot 25-normalized .b 1330 to 2356 1 to 1026   fully sequenced,   1026/1026
(100 %)
11 diff
(99.0 %id)
BM906068 ovary (pool of 3) .b 1339 to 2203 1 to 879       879/1076
(81 %)
48 diff
(95.6 %id)
DA643769   .b 1382 to 1931 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA667563 esophagus .b 1541 to 2102 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
BE744405 adenocarcinoma cell line, ovary .b 1579 to 2361 1 to 777       777/808
(96 %)
11 diff
(98.7 %id)
BE745941 adenocarcinoma cell line, ovary .b 1580 to 2287 1 to 699       699/894
(78 %)
14 diff
(98.5 %id)
BE742771 adenocarcinoma cell line, ovary .b 1580 to 2307 1 to 730       730/905
(80 %)
24 diff
(97.4 %id)
BE740365 adenocarcinoma cell line, ovary .b 1580 to 2229 1 to 649       649/649
(100 %)
3 diff
(99.6 %id)
BE898665 adenocarcinoma cell line, ovary .b 1585 to 2348 8 to 767       760/770
(98 %)
13 diff
(98.4 %id)
AL135584 melanoma (MeWo cell line) .b 1601 to 2103 1 to 503       503/503
(100 %)
0 diff
(100 %id)
AA143678 Pancreas .b 1653 to 2181 1 to 528     Submitted on the opposite strand 528/533
(99 %)
24 diff
(95.5 %id)
CB143761 Liver .b 1686 to 2129 1 to 444       444/444
(100 %)
0 diff
(100 %id)
BG108517 Bone, osteosarcoma, cell line .b 1702 to 2447 1 to 739       739/744
(99 %)
34 diff
(95.5 %id)
BF981443 duodenal adenocarcinoma, cell line, small intestine .b 1809 to 2572 1 to 768       768/936
(82 %)
20 diff
(97.9 %id)
CR978585 T-Lymphocytes .b 1939 to 2733 1 to 796       796/805
(98 %)
3 diff
(99.7 %id)
CN282033 embryonic stem cells, DMSO-treated H9 cellline .b 2077 to 2408 11 to 342       332/342
(97 %)
6 diff
(98.3 %id)
BC063628 Pancreas, epithelioid carcinoma .b 2298 to 3311 1 to 1014   available from MGC, AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 1014/1014
(100 %)
0 diff
(100 %id)
AL578426 placenta .b 2301 to 3304 1003 to 1       1003/1003
(100 %)
19 diff
(98.2 %id)
CN292829 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 2358 to 2803 1 to 445       445/445
(100 %)
5 diff
(98.9 %id)
BE903852 epithelioid carcinoma, Pancreas .b 2397 to 3011 107 to 729   available from MGC,   687/1026
(66 %)
41 diff
(96.1 %id)
BX406814 fetal liver, Liver .b 2411 to 3307 901 to 1       901/901
(100 %)
18 diff
(98.1 %id)
CR601122 HeLa cells Cot 25-normalized .b 2439 to 3279 1 to 841       841/841
(100 %)
0 diff
(100 %id)
BX342333   .b 2439 to 3315 1 to 877   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 877/877
(100 %)
13 diff
(98.6 %id)
BX402973   .b 2439 to 3311 1 to 872   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 872/872
(100 %)
8 diff
(99.1 %id)
BX342332   .b 2446 to 3279 837 to 1       837/844
(99 %)
16 diff
(98.2 %id)
BX386731   .b 2446 to 3236 830 to 42       789/837
(94 %)
0 diff
(100 %id)
AA329340   .b 2465 to 2755 1 to 292       292/292
(100 %)
2 diff
(99.4 %id)
TI_57189968   .b 2473 to 3115 52 to 695       644/644
(100 %)
1 diff
(99.9 %id)
BC047040 Breast, mammary adenocarcinoma. .b 2474 to 3311 1 to 838   available from MGC, AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 838/838
(100 %)
0 diff
(100 %id)
BI860141 breast, mammary adenocarcinoma, cell line .b 2474 to 3115 1 to 643   available from MGC,   643/643
(100 %)
1 diff
(99.9 %id)
AA251523 germinal center B cell .b 2504 to 2708 1 to 207       207/207
(100 %)
3 diff
(98.6 %id)
AW967628   .b 2516 to 3038 1 to 525       525/525
(100 %)
13 diff
(97.6 %id)
BM707960 eye, RPE and Choroid .b 2539 to 2903 1 to 364   fully sequenced, Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 364/364
(100 %)
0 diff
(100 %id)
TI_154034522   .b 2570 to 3327 779 to 36       744/836
(88 %)
0 diff
(100 %id)
BQ000030 Fibrosarcoma .b 2616 to 3329 714 to 1       714/714
(100 %)
0 diff
(100 %id)
CB241374 Human Lung Epithelial cells, lung .b 2620 to 3341 738 to 17   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 722/722
(100 %)
0 diff
(100 %id)
N46622 multiple sclerosis lesions .b 2664 to 2856 1 to 190       190/195
(97 %)
9 diff
(95.4 %id)
EL949384 eyeball .b 2727 to 3219 1 to 493       493/493
(100 %)
5 diff
(99.0 %id)
CA443605 lung, Metastatic Chondrosarcoma .b 2739 to 3322 583 to 2       582/583
(99 %)
0 diff
(100 %id)
AI870399 anaplastic oligodendroglioma, brain .b 2812 to 3334 526 to 3       524/526
(99 %)
0 diff
(100 %id)
AI949529 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 2822 to 3342 521 to 1   tiling clone,   521/521
(100 %)
0 diff
(100 %id)
AI889732 adenocarcinoma, Pancreas .b 2825 to 3316 492 to 1       492/492
(100 %)
0 diff
(100 %id)
AI871690 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 2838 to 3315 478 to 1       478/478
(100 %)
0 diff
(100 %id)
AI493986 uterus .b 2857 to 3341 483 to 1       483/483
(100 %)
3 diff
(99.4 %id)
AA570708 adrenal adenoma, adrenal gland .b 2873 to 3310 438 to 1       438/438
(100 %)
0 diff
(100 %id)
BU731822 eye, RPE and Choroid .b 2873 to 3341 487 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 469/469
(100 %)
0 diff
(100 %id)
AA830473 germinal center B cell .b 2884 to 3333 461 to 12   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 450/450
(100 %)
0 diff
(100 %id)
AA769808   .b 2903 to 3344 442 to 2       441/442
(99 %)
0 diff
(100 %id)
AA844702   .b 2909 to 3334 429 to 4       426/429
(99 %)
0 diff
(100 %id)
AI653883 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 2920 to 3333 414 to 1       414/414
(100 %)
2 diff
(99.6 %id)
AW768563 lymph node, lymphoma, follicular mixed small and largecell .b 2923 to 3320 401 to 4       398/401
(99 %)
0 diff
(100 %id)
AA442846.
matches multiple genes
  .b 2927 to 3314 388 to 1     also hits gene LOC348840 388/388
(100 %)
2 diff
(99.5 %id)
AA437017.
matches multiple genes
  .b 2934 to 3296 1 to 363     also hits gene RANBP3 363/363
(100 %)
3 diff
(99.2 %id)
DB315605 brain .b 2937 to 3315 380 to 1       380/380
(100 %)
1 diff
(99.8 %id)
AW273448 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 2944 to 3324 381 to 1       381/381
(100 %)
1 diff
(99.8 %id)
AW628781 pooled .b 2950 to 3315 386 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 368/392
(93 %)
3 diff
(99.3 %id)
AA748587 germinal center B cell .b 2955 to 3334 388 to 9       380/388
(97 %)
0 diff
(100 %id)
AA251524 germinal center B cell .b 2972 to 3341 370 to 1       370/378
(97 %)
0 diff
(100 %id)
AA716558 heart .b 2976 to 3196 221 to 1       221/221
(100 %)
0 diff
(100 %id)
AI538925 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .b 2977 to 3314 340 to 1       340/341
(99 %)
3 diff
(99.2 %id)
BU625273 cell lines, Enchondroma .b 2983 to 3315 351 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 333/333
(100 %)
0 diff
(100 %id)
AW439601 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 2986 to 3315 331 to 1       331/331
(100 %)
4 diff
(98.8 %id)
AI432295 pooled .b 2995 to 3333 343 to 4       340/343
(99 %)
0 diff
(100 %id)
BQ027653 mixed .b 2998 to 3341 360 to 17   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 344/351
(98 %)
4 diff
(98.9 %id)
AA989242 carcinoid, lung .b 3009 to 3315 307 to 1       307/307
(100 %)
0 diff
(100 %id)
BG056795 anaplastic oligodendroglioma, brain .b 3020 to 3340 321 to 1       321/321
(100 %)
0 diff
(100 %id)
N34896 multiple sclerosis lesions .b 3070 to 3346 276 to 1   tiling clone,   276/276
(100 %)
2 diff
(99.3 %id)
DB322070   .b 3081 to 3341 259 to 1       259/265
(97 %)
3 diff
(98.9 %id)
EX571722 intestinal (Lauren) gastric adenocarcinoma, stomach .b 3124 to 3220 1 to 98       98/98
(100 %)
1 diff
(99.0 %id)
AL573520 placenta, Placenta Cot 25-normalized .b 3157 to 3273 117 to 1   fully sequenced,   767/767
(100 %)
42 diff
(94.6 %id)
FN054420 breast carcinoma .b 3161 to 3269 1 to 109       109/109
(100 %)
0 diff
(100 %id)
BF718572 epidermis, skin .b 3260 to 3309 50 to 1       50/50
(100 %)
0 diff
(100 %id)
AK298408 Liver .c 1 to 1755 1 to 1755 H129R F219L tiling clone,   1755/1755
(100 %)
4 diff
(99.8 %id)
DC362657 Liver .c 1 to 535 1 to 535       535/535
(100 %)
2 diff
(99.7 %id)
AI671354 Kidney .c 54 to 459 406 to 1       406/406
(100 %)
1 diff
(99.8 %id)
AB209730 brain .c 352 to 2823 1 to 2472   tiling clone,   2472/2472
(100 %)
2 diff
(100.0 %id)
BX438469 neuroblastoma .d 1 to 1083 1 to 1073   tiling clone,   1073/1081
(99 %)
22 diff
(98.0 %id)
TI_57179710   .d 6 to 835 62 to 889       828/889
(93 %)
11 diff
(98.8 %id)
BI770440 pooled lung and spleen .d 14 to 835 1 to 821   tiling clone,   821/821
(100 %)
5 diff
(99.4 %id)
TI_57181407   .d 108 to 810 65 to 776       712/800
(89 %)
25 diff
(96.9 %id)
CK000402 mixed .d 525 to 1294 1 to 765   tiling clone,   765/776
(98 %)
11 diff
(98.6 %id)
H43176 brain .d 768 to 1023 1 to 254       254/254
(100 %)
3 diff
(98.9 %id)
H46162 brain .d 768 to 1076 1 to 308       308/308
(100 %)
4 diff
(98.8 %id)
BC068564 Placenta, normal .e 1 to 2562 1 to 2562 exact tiling clone, AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 2562/2564
(99 %)
2 diff
(100.0 %id)
CB988299 Human Placenta, placenta .e 1 to 433 28 to 461       434/855
(50 %)
12 diff
(98.6 %id)
DB086232 testis .e 2 to 271 2 to 271   capped   270/270
(100 %)
4 diff
(98.6 %id)
CN282103 embryonic stem cells, cell lines H1, H7, andH9 .e 13 to 191 1 to 179       179/179
(100 %)
2 diff
(98.9 %id)
BF528697 anaplastic oligodendroglioma with 1p/19qloss, brain .e 517 to 1047 1 to 549       549/1105
(49 %)
22 diff
(98.1 %id)
BQ643336 lymph, lymphoma, cell line .e 573 to 1448 1 to 887   AAA   887/900
(98 %)
24 diff
(97.4 %id)
BU854735 ovary, teratocarcinoma, cell line .e 582 to 1472 1 to 900       900/914
(98 %)
20 diff
(97.9 %id)
DB030782 testis .e 593 to 1186 2 to 595   capped   594/594
(100 %)
0 diff
(100 %id)
BP219907 caudate nucleus .e 647 to 1232 1 to 586       586/586
(100 %)
0 diff
(100 %id)
DA147250 amygdala .e 747 to 1334 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
CN282034 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 800 to 1406 23 to 629       607/629
(96 %)
8 diff
(98.8 %id)
BX281632 pooled lung and spleen .e 834 to 1327 1 to 494       494/494
(100 %)
0 diff
(100 %id)
CD244307 testis .e 845 to 1354 1 to 507       507/531
(95 %)
4 diff
(99.3 %id)
AA580957 bulk germ cell seminoma .e 1291 to 1458 167 to 1       167/167
(100 %)
2 diff
(98.9 %id)
AA724300 pooled .e 2278 to 2505 228 to 1       228/228
(100 %)
3 diff
(98.7 %id)
BC062562 Ovary, teratocarcinoma .f 1 to 3157 1 to 3158 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 3158/3158
(100 %)
5 diff
(99.9 %id)
NM_024881.4   .f 1 to 5091 1 to 5091 exact RefSeq, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 5091/5091
(100 %)
0 diff
(100 %id)
AW451150   .f 26 to 379 1 to 352     Submitted on the opposite strand 352/352
(100 %)
3 diff
(99.2 %id)
BF516582   .f 26 to 475 1 to 450     Submitted on the opposite strand 450/450
(100 %)
0 diff
(100 %id)
AA873456 2 pooled tumors (clear cell type), Kidney .f 140 to 258 1 to 119     Submitted on the opposite strand 119/119
(100 %)
3 diff
(97.5 %id)
DA498411 brain .f 199 to 755 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
AK027699   .f 207 to 3157 1 to 2949   available from FLJ,   2949/2949
(100 %)
1 diff
(100.0 %id)
DA737426   .f 208 to 1020 2 to 813   capped   812/874
(92 %)
7 diff
(99.2 %id)
AA884264 pooled .f 275 to 774 19 to 515     Submitted on the opposite strand 497/516
(96 %)
13 diff
(97.5 %id)
DA054830 cerebellum .f 310 to 854 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
BX364163   .f 353 to 1119 1 to 766       766/777
(98 %)
7 diff
(99.1 %id)
BG747689 eye, normal pigmented retinal epithelium .f 354 to 1260 1 to 919       919/1018
(90 %)
28 diff
(97.3 %id)
DN990865 brain, whole brain .f 358 to 975 9 to 626       618/626
(98 %)
7 diff
(98.9 %id)
DA840670 placenta .f 407 to 957 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
BM467834 leiomyosarcoma, uterus .f 439 to 1270 8 to 847       838/1132
(74 %)
50 diff
(95.6 %id)
BI457033 epithelioid carcinoma cell line, Pancreas .f 492 to 1325 1 to 837       837/899
(93 %)
42 diff
(95.4 %id)
TI_45133820   .f 492 to 1325 59 to 895       837/899
(93 %)
42 diff
(95.4 %id)
AW249358 lung, small cell carcinoma .f 509 to 956 21 to 468       450/468
(96 %)
7 diff
(98.6 %id)
BF841650 head_neck .f 514 to 917 1 to 410       410/410
(100 %)
22 diff
(94.7 %id)
BP298609   .f 517 to 1079 1 to 564       564/564
(100 %)
3 diff
(99.5 %id)
CA395288 eye, RPE/choroid .f 526 to 905 12 to 391       380/391
(97 %)
9 diff
(97.7 %id)
DA633509 Kidney .f 527 to 1058 2 to 533   capped   532/532
(100 %)
1 diff
(99.9 %id)
BF379274 uterus_tumor .f 540 to 760 7 to 227       221/229
(96 %)
10 diff
(95.7 %id)
BM755507 Ascites, stomach .f 561 to 924 1 to 364       364/364
(100 %)
7 diff
(98.1 %id)
DA731807   .f 563 to 1292 2 to 732   capped   731/731
(100 %)
9 diff
(98.8 %id)
CD722391 eye, lacrimal gland .f 584 to 1193 1 to 610       610/610
(100 %)
1 diff
(99.9 %id)
AK027850 placenta .f 590 to 3157 1 to 2568   tiling clone, available from FLJ,   2568/2568
(100 %)
1 diff
(100.0 %id)
DA833598 placenta .f 591 to 1286 2 to 703   capped   702/739
(94 %)
10 diff
(98.7 %id)
DA992505 synovial membrane tissue from rheumatioidarthritis .f 602 to 1133 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
BM904668 leiomyosarcoma, uterus .f 633 to 1533 12 to 926       915/1109
(82 %)
44 diff
(96.1 %id)
CF265149 Brain glioblastoma .f 664 to 1529 1 to 866       866/866
(100 %)
6 diff
(99.4 %id)
DA587170 lung .f 689 to 913 2 to 226   capped   225/225
(100 %)
0 diff
(100 %id)
DA761378 tongue .f 689 to 1193 2 to 506   capped   505/505
(100 %)
2 diff
(99.7 %id)
DA578414   .f 711 to 1267 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA700207   .f 721 to 1224 2 to 505   capped   504/504
(100 %)
0 diff
(100 %id)
DB010786 colon, tumor tissue .f 745 to 1333 2 to 591   capped   590/590
(100 %)
2 diff
(99.7 %id)
CA390428 eye, RPE/choroid .f 830 to 1324 1 to 495     Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 495/495
(100 %)
1 diff
(99.8 %id)
DA021510   .f 851 to 1420 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DB121918 thymus .f 866 to 1368 2 to 504   capped   503/503
(100 %)
0 diff
(100 %id)
BP292452 lung .f 869 to 1419 1 to 550       550/550
(100 %)
10 diff
(98.2 %id)
AW407562 lymph .f 891 to 1202 1 to 312       312/312
(100 %)
7 diff
(97.8 %id)
AW408042 lymph .f 891 to 1293 1 to 403       403/403
(100 %)
9 diff
(97.8 %id)
BF342728 brain, glioblastoma with EGFR amplification .f 901 to 1564 1 to 665       665/914
(72 %)
17 diff
(98.2 %id)
BF526368 brain, glioblastoma with EGFR amplification .f 903 to 1674 1 to 776       776/780
(99 %)
33 diff
(95.8 %id)
DA601510   .f 924 to 1487 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
BP345761 synovial membrane .f 935 to 1514 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BP346445 synovial membrane .f 935 to 1515 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
BE172835 head_neck .f 970 to 1245 1 to 279       279/279
(100 %)
4 diff
(98.6 %id)
BX370427   .f 972 to 1586 620 to 1     Submitted on the opposite strand 620/620
(100 %)
10 diff
(98.4 %id)
BI918395 brain .f 975 to 1682 737 to 29     Submitted on the opposite strand 709/737
(96 %)
0 diff
(100 %id)
TI_57238205   .f 975 to 1682 737 to 29     Submitted on the opposite strand 709/737
(96 %)
0 diff
(100 %id)
BP344631 synovial membrane .f 1017 to 1593 1 to 577       577/579
(99 %)
16 diff
(97.3 %id)
DA290090 hippocampus .f 1019 to 1592 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA585124 lung .f 1021 to 1554 2 to 535   capped   534/534
(100 %)
1 diff
(99.9 %id)
DA370579 thalamus .f 1026 to 1588 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DB193001 ovary, tumor tissue .f 1040 to 1490 2 to 454   capped   453/453
(100 %)
4 diff
(99.2 %id)
BE269184 Burkitt lymphoma, lymph .f 1104 to 1687 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BF374312 stomach .f 1189 to 1678 501 to 10       492/679
(72 %)
0 diff
(100 %id)
BU596605 mixed (pool of 40 RNAs) .f 1211 to 2003 1 to 793       793/794
(99 %)
5 diff
(99.4 %id)
CN263112 embryonic stem cells, cell lines H1, H7, andH9 .f 1251 to 2027 1 to 777       777/777
(100 %)
1 diff
(99.9 %id)
DA613729   .f 1260 to 1848 2 to 591   capped   590/590
(100 %)
1 diff
(99.9 %id)
BQ708653 Spleen .f 1271 to 2191 1 to 924       924/956
(96 %)
10 diff
(99.0 %id)
BX384247   .f 1280 to 2299 1015 to 1     Submitted on the opposite strand 1015/1033
(98 %)
19 diff
(98.2 %id)
BE004187 breast_normal .f 1301 to 1613 324 to 12     Submitted on the opposite strand 313/324
(96 %)
0 diff
(100 %id)
AW751261 colon .f 1355 to 1766 1 to 412       412/412
(100 %)
1 diff
(99.8 %id)
BG824342 adenocarcinoma cell line, colon .f 1417 to 2165 1 to 750       750/964
(77 %)
16 diff
(98.4 %id)
CA306537 Alveolar Macrophage, lung .f 1468 to 2069 620 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 602/602
(100 %)
3 diff
(99.6 %id)
BF330083 breast_normal .f 1486 to 1930 1 to 444       444/444
(100 %)
8 diff
(98.2 %id)
BF363307 nervous_normal .f 1487 to 1928 1 to 439       439/439
(100 %)
12 diff
(97.3 %id)
BF330072 breast_normal .f 1488 to 1916 1 to 427       427/427
(100 %)
9 diff
(97.9 %id)
BE793888 lung, small cell carcinoma .f 1488 to 2265 1 to 774       774/984
(78 %)
15 diff
(98.5 %id)
BF363296 nervous_normal .f 1491 to 1890 1 to 399       399/399
(100 %)
7 diff
(98.3 %id)
BF372997 prostate_tumor .f 1491 to 1787 1 to 297       297/297
(100 %)
4 diff
(98.7 %id)
BF372977 prostate_tumor .f 1492 to 1917 1 to 425       425/425
(100 %)
8 diff
(98.2 %id)
BF372988 prostate_tumor .f 1492 to 1861 1 to 369       369/369
(100 %)
4 diff
(99.0 %id)
BF372995 prostate_tumor .f 1492 to 1915 1 to 422       422/422
(100 %)
8 diff
(98.2 %id)
BF330063 breast_normal .f 1493 to 1875 1 to 381       381/381
(100 %)
7 diff
(98.2 %id)
BF330095 breast_normal .f 1493 to 1899 1 to 408       408/408
(100 %)
10 diff
(97.6 %id)
BQ372843 prostate_tumor .f 1494 to 1793 306 to 1       306/308
(99 %)
16 diff
(94.9 %id)
BF330060 breast_normal .f 1495 to 1907 1 to 410       410/410
(100 %)
9 diff
(97.9 %id)
BF330092 breast_normal .f 1495 to 1908 1 to 415       415/415
(100 %)
9 diff
(97.9 %id)
BF330078 breast_normal .f 1497 to 1871 1 to 372       372/372
(100 %)
5 diff
(98.7 %id)
BF330096 breast_normal .f 1497 to 1915 1 to 418       418/418
(100 %)
6 diff
(98.6 %id)
BF330066 breast_normal .f 1498 to 1858 1 to 361       361/361
(100 %)
6 diff
(98.4 %id)
BF330082 breast_normal .f 1499 to 1989 1 to 489       489/489
(100 %)
10 diff
(98.0 %id)
BF330055 breast_normal .f 1500 to 1878 1 to 374       374/374
(100 %)
11 diff
(97.1 %id)
BF330070 breast_normal .f 1500 to 1965 1 to 461       461/461
(100 %)
8 diff
(98.3 %id)
BF330088 breast_normal .f 1500 to 1894 9 to 402       394/402
(98 %)
4 diff
(99.1 %id)
BF330098 breast_normal .f 1500 to 1896 1 to 398       398/398
(100 %)
8 diff
(98.0 %id)
BF330069 breast_normal .f 1501 to 1948 15 to 460       446/460
(96 %)
6 diff
(98.7 %id)
BF363289 nervous_normal .f 1503 to 1890 1 to 387       387/387
(100 %)
5 diff
(98.8 %id)
BF330075 breast_normal .f 1505 to 1976 1 to 470       470/470
(100 %)
5 diff
(99.0 %id)
BF372989 prostate_tumor .f 1507 to 1924 1 to 421       421/421
(100 %)
9 diff
(97.9 %id)
BF734845 bladder_tumor .f 1507 to 1668 165 to 3     Submitted on the opposite strand 163/200
(81 %)
0 diff
(100 %id)
BF372993 prostate_tumor .f 1509 to 1920 4 to 414       411/414
(99 %)
8 diff
(98.1 %id)
BF363293 nervous_normal .f 1519 to 1892 1 to 375       375/375
(100 %)
6 diff
(98.4 %id)
BG468599 adenocarcinoma cell line, colon .f 1576 to 2296 1 to 719       719/916
(78 %)
42 diff
(95.5 %id)
AA328000   .f 1597 to 1894 1 to 301       301/306
(98 %)
5 diff
(98.4 %id)
TI_151728032   .f 1617 to 2287 733 to 65       669/776
(86 %)
0 diff
(100 %id)
BM726930 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 1628 to 2269 1 to 642       642/642
(100 %)
2 diff
(99.7 %id)
AA362575   .f 1649 to 1917 1 to 269       269/269
(100 %)
0 diff
(100 %id)
BF372992 prostate_tumor .f 1663 to 1952 291 to 1       291/291
(100 %)
3 diff
(99.0 %id)
BE700883 nervous_normal .f 1668 to 2121 464 to 12       453/464
(97 %)
0 diff
(100 %id)
BI090212 cervix .f 1677 to 2463 1 to 785       785/785
(100 %)
22 diff
(97.2 %id)
BE700891 nervous_normal .f 1679 to 2121 462 to 19       444/462
(96 %)
0 diff
(100 %id)
BE772076 prostate_tumor .f 1681 to 2121 456 to 16       441/456
(96 %)
0 diff
(100 %id)
AA352967   .f 1688 to 2073 1 to 392       392/394
(99 %)
11 diff
(97.3 %id)
BE700860 nervous_normal .f 1693 to 2121 429 to 2       428/429
(99 %)
0 diff
(100 %id)
BE700929 nervous_normal .f 1699 to 2121 428 to 7       422/428
(98 %)
0 diff
(100 %id)
BE818932 breast_normal .f 1700 to 2121 441 to 20       422/441
(95 %)
0 diff
(100 %id)
BP332393 renal proximal tubule .f 1705 to 2285 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BE700890 nervous_normal .f 1711 to 2118 427 to 20       408/427
(95 %)
0 diff
(100 %id)
BE700887 nervous_normal .f 1718 to 2121 419 to 17       403/419
(96 %)
0 diff
(100 %id)
DA766516 tongue .f 1737 to 2206 2 to 472   capped   471/472
(99 %)
4 diff
(99.2 %id)
BE700916 nervous_normal .f 1742 to 2121 389 to 10       380/389
(97 %)
0 diff
(100 %id)
AA310538   .f 1744 to 2169 1 to 428       428/430
(99 %)
4 diff
(99.1 %id)
CN263113 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 1745 to 2339 1 to 595       595/595
(100 %)
0 diff
(100 %id)
BE348724 carcinoid, lung .f 1745 to 2278 534 to 1       534/534
(100 %)
0 diff
(100 %id)
BU854791 ovary, teratocarcinoma, cell line .f 1745 to 2594 871 to 10     Submitted on the opposite strand 862/919
(93 %)
0 diff
(100 %id)
BG924220 cartilage .f 1755 to 2108 75 to 428       354/362
(97 %)
6 diff
(98.4 %id)
BG926967 cartilage .f 1755 to 2111 75 to 431       357/363
(98 %)
6 diff
(98.4 %id)
BE772071 prostate_tumor .f 1761 to 2115 356 to 1       356/356
(100 %)
2 diff
(99.5 %id)
BE772069 prostate_tumor .f 1763 to 2114 362 to 10       353/362
(97 %)
0 diff
(100 %id)
BE818937 breast_normal .f 1767 to 2118 359 to 6       354/359
(98 %)
0 diff
(100 %id)
BF237991 leiomyosarcoma cell line, uterus .f 1775 to 2311 1 to 536       536/537
(99 %)
5 diff
(99.1 %id)
BG339681 leiomyosarcoma cell line, uterus .f 1775 to 2556 1 to 766       766/979
(78 %)
29 diff
(97.1 %id)
BC007731 Uterus, leiomyosarcoma .f 1776 to 3157 1 to 1383   available from MGC, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 1383/1383
(100 %)
1 diff
(100.0 %id)
BF744954 breast .f 1786 to 2096 313 to 1     Submitted on the opposite strand 313/313
(100 %)
0 diff
(100 %id)
BE818978 breast_normal .f 1814 to 2127 323 to 10       314/323
(97 %)
0 diff
(100 %id)
BE904333 epithelioid carcinoma, Pancreas .f 1829 to 2634 1 to 798       798/891
(89 %)
37 diff
(95.9 %id)
CB154403 brain .f 1865 to 2470 1 to 606       606/606
(100 %)
0 diff
(100 %id)
DA553477   .f 1869 to 2347 2 to 481   capped   480/480
(100 %)
1 diff
(99.8 %id)
BU153681 epithelioid carcinoma, Pancreas .f 1930 to 2571 690 to 41   AAA Submitted on the opposite strand 650/788
(82 %)
11 diff
(98.7 %id)
BG012246 placenta_normal .f 1943 to 2349 1 to 403       403/403
(100 %)
13 diff
(96.8 %id)
BQ672824 epidermoid carcinoma, cell line, salivary gland .f 1943 to 2715 1 to 782       782/869
(89 %)
42 diff
(95.2 %id)
BE772088 prostate_tumor .f 1989 to 2121 135 to 3       133/135
(98 %)
0 diff
(100 %id)
CA390427 eye, RPE/choroid .f 1996 to 2571 592 to 17   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 576/576
(100 %)
0 diff
(100 %id)
BG122285 adenocarcinoma, cell line, Liver .f 2002 to 2571 72 to 641   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 570/641
(88 %)
6 diff
(99.1 %id)
BM009120 amelanotic melanoma, cell line, skin .f 2141 to 2750 1 to 613       613/613
(100 %)
12 diff
(98.1 %id)
TI_59383835   .f 2142 to 2750 71 to 682       612/612
(100 %)
11 diff
(98.3 %id)
BM809105 amelanotic melanoma, cell line, skin .f 2143 to 3067 1 to 922       922/1135
(81 %)
12 diff
(99.0 %id)
BM915174 amelanotic melanoma, cell line, skin .f 2143 to 3045 1 to 916       916/1019
(89 %)
18 diff
(98.3 %id)
BU963252 mixed (pool of 40 RNAs) .f 2159 to 2577 1 to 419       419/449
(93 %)
3 diff
(99.4 %id)
BU539739 adenocarcinoma, cell line, breast .f 2202 to 3040 1 to 846       846/847
(99 %)
13 diff
(98.5 %id)
AI753898 bone marrow stroma .f 2208 to 2571 383 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 365/365
(100 %)
3 diff
(99.2 %id)
AW248940 lung, small cell carcinoma .f 2216 to 2581 366 to 1       366/366
(100 %)
2 diff
(99.5 %id)
BM556037 duodenal adenocarcinoma, cell line, small intestine .f 2220 to 3039 1 to 822       822/1006
(81 %)
26 diff
(97.5 %id)
BE180234 head_neck .f 2362 to 2777 7 to 421       415/422
(98 %)
6 diff
(98.6 %id)
BE707514 head_neck .f 2367 to 2722 355 to 1       355/355
(100 %)
16 diff
(95.5 %id)
AW068268 Bone, Hip .f 2415 to 2734 1 to 320       320/320
(100 %)
5 diff
(98.5 %id)
BI021111 marrow .f 2482 to 2845 1 to 363       363/363
(100 %)
2 diff
(99.5 %id)
BU539887 mixed (pool of 40 RNAs) .f 2515 to 3101 1 to 591       591/743
(79 %)
13 diff
(98.3 %id)
CB116336 Liver .f 2530 to 3040 1 to 510       510/510
(100 %)
5 diff
(99.1 %id)
DB370025   .f 2538 to 3157 609 to 1       609/610
(99 %)
19 diff
(96.9 %id)
BQ434470 melanotic melanoma, skin .f 2539 to 3157 1 to 619   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 619/619
(100 %)
1 diff
(99.9 %id)
BQ686778 ductal carcinoma, cell line, Pancreas .f 2555 to 3163 1 to 610       610/610
(100 %)
1 diff
(99.9 %id)
AA355142   .f 2558 to 2851 1 to 296       296/297
(99 %)
5 diff
(98.4 %id)
AW958460   .f 2584 to 3179 1 to 596       596/605
(98 %)
15 diff
(97.6 %id)
BG476701 melanotic melanoma, skin .f 2586 to 3177 1 to 591       591/592
(99 %)
5 diff
(99.2 %id)
AW023615 cochlea, ear .f 2587 to 2768 1 to 182   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 182/182
(100 %)
4 diff
(97.9 %id)
EC457799 Prostate .f 2604 to 2704 1 to 102       102/102
(100 %)
2 diff
(98.1 %id)
BE728360 melanotic melanoma, skin .f 2606 to 3157 1 to 551       551/551
(100 %)
1 diff
(99.9 %id)
BE729928 melanotic melanoma, skin .f 2606 to 3155 1 to 540       540/540
(100 %)
10 diff
(98.2 %id)
BE275174 melanotic melanoma, skin .f 2607 to 3156 1 to 544       544/544
(100 %)
6 diff
(98.9 %id)
BE728264 melanotic melanoma, skin .f 2607 to 3157 1 to 548       548/548
(100 %)
3 diff
(99.5 %id)
BE389774 endometrium, adenocarcinoma cell line, uterus .f 2608 to 3155 1 to 547       547/547
(100 %)
1 diff
(99.9 %id)
BE729585 melanotic melanoma, skin .f 2609 to 3156 1 to 540       540/540
(100 %)
10 diff
(98.2 %id)
BF957385 nervous_normal .f 2613 to 2791 207 to 28       180/207
(86 %)
0 diff
(100 %id)
BF342223 brain, glioblastoma with EGFR amplification .f 2613 to 3157 12 to 555   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 544/555
(98 %)
6 diff
(99.0 %id)
AA639278   .f 2632 to 3165 535 to 1       535/535
(100 %)
1 diff
(99.9 %id)
TI_154148776   .f 2653 to 3153 581 to 83     Submitted on the opposite strand 499/499
(100 %)
9 diff
(98.2 %id)
DB380420 placenta .f 2674 to 3157 488 to 1       488/488
(100 %)
8 diff
(98.4 %id)
AA599241 bone marrow stroma .f 2677 to 3155 478 to 1       478/478
(100 %)
1 diff
(99.8 %id)
AI913307 adenocarcinoma, Pancreas .f 2680 to 3162 483 to 1       483/483
(100 %)
2 diff
(99.6 %id)
AW021154 cochlea, ear .f 2705 to 3157 2 to 454   fully sequenced, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 453/454
(99 %)
6 diff
(98.7 %id)
BX113018 adenocarcinoma, Pancreas .f 2706 to 3171 466 to 1     Submitted on the opposite strand 466/466
(100 %)
2 diff
(99.6 %id)
AI128858 senescent fibroblast .f 2731 to 3162 431 to 1       431/431
(100 %)
4 diff
(99.1 %id)
DA730617   .f 2732 to 3402 2 to 670   capped   669/669
(100 %)
3 diff
(99.6 %id)
DA345516 substantia nigra .f 2739 to 3198 2 to 463   tiling clone, capped   462/462
(100 %)
2 diff
(99.6 %id)
AA657534   .f 2749 to 3155 7 to 412       406/412
(98 %)
2 diff
(99.6 %id)
BI492100 cochlea, ear .f 2751 to 3162 412 to 1   fully sequenced, Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 412/412
(100 %)
1 diff
(99.8 %id)
BG112722 Bone, osteosarcoma, cell line .f 2761 to 3178 1 to 416       416/416
(100 %)
5 diff
(98.8 %id)
AW068020 Bone, Hip .f 2761 to 3158 408 to 9       400/408
(98 %)
3 diff
(99.3 %id)
BP238221 Liver .f 2798 to 3411 1 to 614       614/614
(100 %)
14 diff
(97.8 %id)
TI_154099348   .f 3120 to 3749 221 to 849   tiling clone, Submitted on the opposite strand 629/1160
(54 %)
11 diff
(99.1 %id)
AA812693   .f 3142 to 3557 1 to 416     Submitted on the opposite strand 416/416
(100 %)
4 diff
(99.1 %id)
CB241531 Human Lung Epithelial cells, lung .f 3144 to 3902 18 to 780     Submitted on the opposite strand 763/780
(97 %)
6 diff
(99.3 %id)
TI_159713765   .f 3174 to 3846 27 to 701     Submitted on the opposite strand 675/1111
(60 %)
6 diff
(99.5 %id)
BM728861 eye, fetal eye .f 3178 to 3614 1 to 436   fully sequenced, Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 436/436
(100 %)
5 diff
(98.9 %id)
BG254637 adenocarcinoma, cell line, Prostate .f 3197 to 4039 1 to 851       851/929
(91 %)
36 diff
(96.2 %id)
CB158151 Liver .f 3198 to 3815 1 to 616       616/616
(100 %)
1 diff
(99.9 %id)
AW956131   .f 3205 to 3867 1 to 664       664/664
(100 %)
5 diff
(99.3 %id)
BE786116 large cell carcinoma, lung .f 3205 to 3892 1 to 687       687/687
(100 %)
1 diff
(99.9 %id)
CN310779 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f 3209 to 3728 1 to 520       520/520
(100 %)
0 diff
(100 %id)
AA056650 uterus .f 3216 to 3532 1 to 318     Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 318/332
(95 %)
8 diff
(97.6 %id)
BF983761 duodenal adenocarcinoma, cell line, small intestine .f 3232 to 3886 1 to 659       659/696
(94 %)
25 diff
(96.5 %id)
AA370815 Prostate .f 3244 to 3583 1 to 340       340/340
(100 %)
0 diff
(100 %id)
TI_159723873   .f 3266 to 4075 886 to 84   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 803/981
(81 %)
16 diff
(98.4 %id)
TI_227715200   .f 3266 to 4077 894 to 94   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 801/972
(82 %)
10 diff
(99.0 %id)
BF910319 uterus_tumor .f 3276 to 3643 369 to 2     Submitted on the opposite strand 368/369
(99 %)
0 diff
(100 %id)
TI_227715284   .f 3338 to 4077 829 to 93   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 737/980
(75 %)
5 diff
(99.5 %id)
BG010737 placenta_normal .f 3347 to 3714 1 to 368       368/368
(100 %)
2 diff
(99.5 %id)
BF883519 lung_tumor .f 3361 to 3721 386 to 27     Submitted on the opposite strand 360/386
(93 %)
0 diff
(100 %id)
CA944577 Human Lung Epithelial cells, lung .f 3365 to 4075 727 to 17   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 711/711
(100 %)
5 diff
(99.3 %id)
CA503264 Human Lung Epithelial cells, lung .f 3380 to 4075 711 to 17   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 695/695
(100 %)
1 diff
(99.9 %id)
CD365682 Alveolar Macrophage, lung .f 3392 to 4077 704 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 686/686
(100 %)
2 diff
(99.8 %id)
BQ021554 lung, Metastatic Chondrosarcoma .f 3397 to 4073 693 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 675/675
(100 %)
2 diff
(99.8 %id)
BU599078 mixed (pool of 40 RNAs) .f 3412 to 4175 1 to 771       771/773
(99 %)
12 diff
(98.5 %id)
CD365764 Alveolar Macrophage, lung .f 3429 to 4077 667 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 649/649
(100 %)
0 diff
(100 %id)
CD742871 Alveolar Macrophage, lung .f 3430 to 4073 664 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 646/646
(100 %)
2 diff
(99.7 %id)
AW377708 head_neck .f 3436 to 3791 356 to 1       356/356
(100 %)
1 diff
(99.8 %id)
DA812100 ovary, tumor tissue .f 3508 to 4177 2 to 673   capped   672/674
(99 %)
7 diff
(99.0 %id)
FN162565 breast carcinoma .f 3521 to 3593 75 to 1     Submitted on the opposite strand 75/75
(100 %)
2 diff
(97.4 %id)
CN310780 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 3543 to 4100 1 to 559       559/559
(100 %)
2 diff
(99.7 %id)
CN310778 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f 3554 to 4222 1 to 669   tiling clone,   669/669
(100 %)
0 diff
(100 %id)
AW051365 pooled .f 3573 to 4072 505 to 6       500/505
(99 %)
0 diff
(100 %id)
AI767362 2 pooled tumors (clear cell type), Kidney .f 3578 to 4014 452 to 16   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 437/437
(100 %)
4 diff
(99.1 %id)
AW269128 Kidney .f 3578 to 4017 443 to 5       439/443
(99 %)
0 diff
(100 %id)
AA369005 placenta .f 3584 to 3815 1 to 231       231/231
(100 %)
1 diff
(99.6 %id)
BU742764 eye, fetal eye .f 3584 to 4073 508 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 490/490
(100 %)
1 diff
(99.8 %id)
AW953853   .f 3585 to 4073 1 to 489   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 489/489
(100 %)
0 diff
(100 %id)
AW954025   .f 3585 to 4073 1 to 490   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 490/490
(100 %)
3 diff
(99.4 %id)
BF592064 Kidney .f 3604 to 4074 472 to 2       471/472
(99 %)
0 diff
(100 %id)
AI620673 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f 3629 to 4073 445 to 1       445/445
(100 %)
0 diff
(100 %id)
AI300804 2 pooled tumors (clear cell type), Kidney .f 3633 to 4080 450 to 3       448/450
(99 %)
0 diff
(100 %id)
BX100613 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f 3642 to 4073 446 to 15   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 432/432
(100 %)
1 diff
(99.8 %id)
AW118838 pooled .f 3644 to 4074 434 to 4       431/434
(99 %)
0 diff
(100 %id)
CN310781 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 3678 to 4431 9 to 761       753/761
(98 %)
9 diff
(98.9 %id)
AI087204 senescent fibroblast .f 3684 to 4073 400 to 11   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 390/390
(100 %)
0 diff
(100 %id)
AW511105 pooled .f 3706 to 4076 374 to 4       371/374
(99 %)
0 diff
(100 %id)
AA884803 pooled .f 3738 to 4074 340 to 5       336/340
(98 %)
0 diff
(100 %id)
BQ356341 head_neck .f 3754 to 3795 48 to 4       220/258
(85 %)
4 diff
(98.5 %id)
AI912868 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .f 3759 to 4195 460 to 24       437/460
(95 %)
0 diff
(100 %id)
DV460372 cochlea, ear .f 3770 to 3883 1 to 114       114/114
(100 %)
1 diff
(99.2 %id)
BG993435 head_neck .f 3799 to 4193 400 to 7       394/400
(98 %)
0 diff
(100 %id)
AW137369   .f 3817 to 4080 278 to 15       264/278
(94 %)
0 diff
(100 %id)
G36508   .f 3843 to 4073 251 to 21   AAA Submitted on the opposite strand 231/231
(100 %)
0 diff
(100 %id)
AA056484 uterus .f 3843 to 4073 251 to 21   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 231/231
(100 %)
0 diff
(100 %id)
AA742863   .f 3850 to 4179 336 to 7       330/336
(98 %)
0 diff
(100 %id)
AK094008 uterus .f 3879 to 5091 1 to 1213   tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 1213/1213
(100 %)
2 diff
(99.9 %id)
AX748408   .f 3879 to 5091 1 to 1213   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 1213/1213
(100 %)
2 diff
(99.9 %id)
DB253885.
matches multiple genes
uterus .f 3880 to 4428 2 to 550   capped also hits gene PAEP 549/549
(100 %)
0 diff
(100 %id)
DB362522   .f 4557 to 5091 536 to 1   tiling clone,   536/537
(99 %)
11 diff
(98.0 %id)
DB459545 testis .g -11 to 470 1 to 482       482/482
(100 %)
2 diff
(99.6 %id)
BC014595 testis .g -9 to 1262 1 to 1272 L8F tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 1272/1272
(100 %)
4 diff
(99.7 %id)
NM_145046.3   .g -9 to 1275 1 to 1285 exact RefSeq,   1285/1285
(100 %)
0 diff
(100 %id)
BI462994 testis .g 1 to 806 8 to 806       806/806
(100 %)
18 diff
(97.8 %id)
BP369290 testis .g 1 to 578 5 to 581       581/581
(100 %)
4 diff
(99.4 %id)
AK058084 testis .g 1 to 1257 3 to 1259 exact tiling clone, available from FLJ,   1259/1259
(100 %)
2 diff
(99.9 %id)
DB447725.
matches multiple genes
testis .g 1 to 450 3 to 453     also hits gene bawchee 453/453
(100 %)
6 diff
(98.7 %id)
DB067105 testis .g 1 to 538 2 to 539   capped   538/538
(100 %)
1 diff
(99.9 %id)
BP370084 testis .g 11 to 569 1 to 558   tiling clone,   558/558
(100 %)
14 diff
(97.5 %id)
DB445173 testis .g 15 to 449 1 to 436       436/436
(100 %)
5 diff
(98.9 %id)
TI_57171624   .g 20 to 846 40 to 867       828/912
(90 %)
19 diff
(98.0 %id)
TI_57175622   .g 20 to 736 90 to 818       729/882
(82 %)
30 diff
(96.6 %id)
BI827528 brain, medulla .g 21 to 703 1 to 682       682/682
(100 %)
2 diff
(99.8 %id)
TI_57171846   .g 21 to 703 29 to 710       682/710
(96 %)
7 diff
(99.1 %id)
BI827976 brain, medulla .g 25 to 846 1 to 823       823/868
(94 %)
14 diff
(98.4 %id)
BI831833 brain, medulla .g 25 to 606 1 to 582       582/788
(73 %)
10 diff
(98.8 %id)
BI562181 testis .g 36 to 191 1 to 156       156/156
(100 %)
3 diff
(98.1 %id)
TI_1948125300   .g 38 to 862 114 to 940       827/1375
(60 %)
21 diff
(98.5 %id)
TI_1948124236   .g 53 to 973 134 to 1052       919/1272
(72 %)
17 diff
(98.7 %id)
TI_1948124237   .g 53 to 1066 131 to 1141       1011/1336
(75 %)
38 diff
(97.2 %id)
TI_1948124238   .g 53 to 736 125 to 813       689/1353
(50 %)
32 diff
(97.7 %id)
TI_1948124760   .g 53 to 973 132 to 1051       920/1311
(70 %)
18 diff
(98.7 %id)
TI_1948124761   .g 53 to 972 127 to 1044       918/1336
(68 %)
18 diff
(98.7 %id)
TI_1948124762   .g 53 to 966 132 to 1038       907/1304
(69 %)
34 diff
(97.4 %id)
TI_1948125298   .g 53 to 1010 136 to 1090   AAA   955/1295
(73 %)
24 diff
(98.2 %id)
TI_1948125299   .g 53 to 973 126 to 1044       919/1288
(71 %)
15 diff
(98.9 %id)
TI_1948125827   .g 53 to 1071 125 to 1139   AAA   1015/1273
(79 %)
22 diff
(98.3 %id)
TI_1948125828   .g 53 to 972 128 to 1048       921/1359
(67 %)
35 diff
(97.5 %id)
TI_1948125829   .g 53 to 975 125 to 1051       927/1348
(68 %)
38 diff
(97.2 %id)
CV024158 mixed .g 54 to 680 1 to 627       627/627
(100 %)
2 diff
(99.7 %id)
TI_1948124765   .g 143 to 1207 1185 to 129       1057/1401
(75 %)
17 diff
(98.8 %id)
TI_1948125830   .g 143 to 1207 1182 to 123       1060/1362
(77 %)
36 diff
(97.4 %id)
BF979336 testis .g 145 to 500 160 to 513   fully sequenced,   513/513
(100 %)
9 diff
(98.3 %id)
BG716900 testis .g 145 to 701 160 to 717       717/721
(99 %)
13 diff
(98.2 %id)
TI_1948125831   .g 243 to 1207 1089 to 129       961/1380
(69 %)
18 diff
(98.7 %id)
TI_1948125832   .g 243 to 1207 1089 to 128       962/1409
(68 %)
35 diff
(97.6 %id)
TI_1948124240   .g 244 to 1207 1082 to 129       954/1343
(71 %)
29 diff
(97.9 %id)
TI_1948124241   .g 244 to 1207 1096 to 130       967/1430
(67 %)
13 diff
(99.1 %id)
TI_1948124764   .g 244 to 1207 1089 to 129       961/1381
(69 %)
18 diff
(98.7 %id)
TI_1948125302   .g 244 to 1207 1087 to 129       959/1360
(70 %)
16 diff
(98.9 %id)
TI_1948124239   .g 292 to 1207 1049 to 127       923/1421
(64 %)
29 diff
(98.0 %id)
TI_1948124763   .g 442 to 1207 894 to 128       767/1365
(56 %)
7 diff
(99.5 %id)
TI_1948125301   .g 442 to 1207 887 to 122       766/1371
(55 %)
10 diff
(99.3 %id)
BF979888 testis .g 470 to 1191 738 to 15   fully sequenced,   722/736
(98 %)
11 diff
(98.6 %id)
AA910019 pooled .g 790 to 1278 491 to 5   tiling clone,   487/492
(98 %)
14 diff
(97.2 %id)
DB525001 testis .g 803 to 1275 1 to 473     Submitted on the opposite strand 473/473
(100 %)
1 diff
(99.8 %id)
DB510196 testis .g 949 to 1275 1 to 324     Submitted on the opposite strand 324/324
(100 %)
14 diff
(95.7 %id)
AA724299 pooled .g 1095 to 1282 191 to 4       188/191
(98 %)
0 diff
(100 %id)
AK128435 thymus .h-u 1 to 3870 2 to 3871 exact tiling clone, available from FLJ,   3871/3871
(100 %)
3 diff
(100.0 %id)
DB161733 thymus .h-u 1 to 578 2 to 579   capped   578/578
(100 %)
3 diff
(99.5 %id)
DB346906 thymus .h-u 3326 to 3870 548 to 1       548/548
(100 %)
3 diff
(99.5 %id)
BX418859 brain, fetal brain .i 1 to 1088 1 to 1075 L2X A16P tiling clone,   1075/1089
(98 %)
27 diff
(97.6 %id)
BX454875 brain, fetal brain .i 1427 to 2304 881 to 1   tiling clone,   881/882
(99 %)
9 diff
(99.0 %id)
BI520485 brain, medulla .j 1 to 742 1 to 743 V190G I191H S192L S193Q L194P ... tiling clone,   743/743
(100 %)
4 diff
(99.5 %id)
TI_43963904   .j 1 to 742 35 to 777 V190G I191H S192L S193Q L194P ...     743/777
(95 %)
9 diff
(98.9 %id)
CV807410 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .k 1 to 874 1 to 883 exact tiling clone,   883/898
(98 %)
21 diff
(97.7 %id)
DB216968 trachea .l 1 to 549 2 to 550   tiling clone, capped   549/549
(100 %)
0 diff
(100 %id)
BC035039 testis .l 75 to 1420 1 to 1346 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 1346/1346
(100 %)
4 diff
(99.8 %id)
BF511683   .l 874 to 1430 574 to 18   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 557/557
(100 %)
1 diff
(99.9 %id)
BI027710 marrow .l 946 to 1266 8 to 323       316/323
(97 %)
6 diff
(98.2 %id)
BI024555 marrow .l 947 to 1266 8 to 324       317/324
(97 %)
6 diff
(98.2 %id)
BI024556 marrow .l 973 to 1266 1 to 292       292/292
(100 %)
9 diff
(97.0 %id)
BF994145 placenta_normal .l 1101 to 1278 1 to 178       178/188
(94 %)
3 diff
(98.5 %id)
AW449685   .l 1196 to 1430 255 to 18   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 238/240
(99 %)
8 diff
(96.7 %id)
BI459597 testis .m 1 to 827 1 to 822   tiling clone,   822/824
(99 %)
19 diff
(97.7 %id)
AI222024 pooled .n 1 to 425 426 to 2   tiling clone,   425/426
(99 %)
0 diff
(100 %id)
CF272612   .n 281 to 868 588 to 1   tiling clone, Submitted on the opposite strand 588/588
(100 %)
0 diff
(100 %id)
AK024313 ovary, tumor tissue .o 1 to 1904 2 to 1908   tiling clone, available from FLJ,   1908/1908
(100 %)
8 diff
(99.6 %id)
AU134128 ovary, tumor tissue .o 1 to 577 2 to 576   capped   575/584
(98 %)
3 diff
(99.5 %id)
CR457326   .o 277 to 641 1 to 365       365/366
(99 %)
2 diff
(99.5 %id)
BE770161 prostate_tumor .o 377 to 890 1 to 511       511/522
(97 %)
8 diff
(98.5 %id)
AU155227 ovary, tumor tissue .o 1406 to 1904 500 to 1   tiling clone,   500/500
(100 %)
9 diff
(98.2 %id)
BX105710 liver and spleen .o 1866 to 2468 1 to 603   tiling clone,   603/603
(100 %)
0 diff
(100 %id)
BE695918 colon .o 1908 to 2405 30 to 528       499/531
(93 %)
9 diff
(98.4 %id)
AU311590 neuroblastoma .p-u 1 to 545 1 to 548 R7W R14X C51X L54X A99X ... tiling clone,   548/548
(100 %)
4 diff
(99.3 %id)
BF974167 B-cells, primary B-cells from tonsils (cell line) .p-u 561 to 1232 1 to 672   tiling clone, available from MGC,   672/832
(80 %)
13 diff
(98.5 %id)
BC030138 Primary B-Cells from Tonsils .p-u 563 to 1639 1 to 1076   tiling clone, available from MGC, AAA   1076/1076
(100 %)
1 diff
(100.0 %id)
AU311591 neuroblastoma .p-u 1054 to 1629 600 to 22       579/600
(96 %)
0 diff
(100 %id)
BE675584 B-cell, chronic lymphotic leukemia .p-u 1142 to 1620 479 to 1   tiling clone,   479/479
(100 %)
1 diff
(99.8 %id)
AI494542 B-cell, chronic lymphotic leukemia .p-u 1246 to 1620 375 to 1       375/375
(100 %)
0 diff
(100 %id)
AI546966 Prostate .q 1 to 515 21 to 548 K20S Y21T F22S A23R S24P ... tiling clone,   528/771
(68 %)
28 diff
(96.4 %id)
DB071614 testis .r 1 to 551 2 to 552 exact tiling clone, capped   551/551
(100 %)
1 diff
(99.9 %id)
DB072765 testis .s 1 to 538 2 to 539 exact tiling clone, capped   538/538
(100 %)
0 diff
(100 %id)
BC014557 Ovary, adenocarcinoma .t 1 to 2506 1 to 2504 L72S L73S F74S Q76S H77T ... tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 2504/2504
(100 %)
6 diff
(99.8 %id)
BE744311 adenocarcinoma cell line, ovary .t 22 to 748 1 to 724 L72S L73S F74S Q76S H77T ... available from MGC,   724/724
(100 %)
8 diff
(98.9 %id)
CR982656 T-Lymphocytes .u 1 to 554 1 to 554 exact tiling clone,   554/554
(100 %)
0 diff
(100 %id)
CA394103 eye, RPE/choroid .u 470 to 1064 1 to 595   tiling clone,   595/595
(100 %)
0 diff
(100 %id)
DB344553 thymus .va-u 1 to 530 530 to 1 exact tiling clone,   530/530
(100 %)
0 diff
(100 %id)
AW058464 Kidney .va-u 18 to 503 1 to 486     Submitted on the opposite strand 486/486
(100 %)
0 diff
(100 %id)
AA923338 pooled .va-u 19 to 128 1 to 108     Submitted on the opposite strand 108/108
(100 %)
4 diff
(96.3 %id)
BX640756 human rectum tumor .vb 1 to 3688 1 to 3684 D86V tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 3684/3684
(100 %)
3 diff
(100.0 %id)
DA794409 brain .vb 3518 to 3835 2 to 319   tiling clone, capped   318/318
(100 %)
2 diff
(99.4 %id)
BG288107 bladder, transitional cell papilloma, cell line .vb 3597 to 4349 1 to 754   tiling clone,   754/764
(98 %)
19 diff
(97.6 %id)
BG570811 placenta .vb 3733 to 4314 1 to 579   tiling clone,   579/579
(100 %)
9 diff
(98.5 %id)
AL697856 human skeletal muscle .vb 3809 to 4652 1 to 840   tiling clone,   840/840
(100 %)
23 diff
(97.3 %id)
BP418165 small intestine .vb 3934 to 4383 1 to 450     Submitted on the opposite strand 450/450
(100 %)
8 diff
(98.3 %id)
CF139348 CNCAP(3)T-225 cell line, Prostate .vb 3955 to 4365 18 to 428   tiling clone,   411/428
(96 %)
6 diff
(98.6 %id)
TI_154169543   .vb 3955 to 4539 101 to 691       591/947
(62 %)
29 diff
(97.0 %id)
BP425076 small intestine .vb 4003 to 4361 1 to 360     Submitted on the opposite strand 360/360
(100 %)
11 diff
(97.0 %id)
AA470576   .vb 4079 to 4470 1 to 391       391/391
(100 %)
8 diff
(98.0 %id)
BM994564 lung, Metastatic Chondrosarcoma .vb 4092 to 4698 628 to 24   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 605/609
(99 %)
0 diff
(100 %id)
AI659219 Prostate .vb 4164 to 4704 541 to 1   tiling clone,   541/541
(100 %)
0 diff
(100 %id)
BU619655 Cell Line, Chondrosarcoma .vb 4194 to 4702 527 to 19   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 509/639
(79 %)
5 diff
(99.3 %id)
AI962228 pooled germ cell tumors .vb 4217 to 4586 382 to 13   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 370/370
(100 %)
2 diff
(99.5 %id)
BG287758 bladder, transitional cell papilloma, cell line .vb 4225 to 4702 1 to 478   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 478/478
(100 %)
1 diff
(99.8 %id)
CD556534 brain, Pituitary .vb 4226 to 4704 1 to 481       481/515
(93 %)
2 diff
(99.7 %id)
AI452632 pooled .vb 4231 to 4710 480 to 3   tiling clone,   478/480
(99 %)
0 diff
(100 %id)
AI732714   .vb 4235 to 4702 495 to 29   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 467/467
(100 %)
1 diff
(99.8 %id)
AI073694 senescent fibroblast .vb 4238 to 4586 364 to 16   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 349/349
(100 %)
0 diff
(100 %id)
AW138620   .vb 4244 to 4590 360 to 14       347/369
(94 %)
0 diff
(100 %id)
AI687964 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .vb 4301 to 4702 402 to 1       402/402
(100 %)
0 diff
(100 %id)
TI_153991660   .vb 4327 to 4702 458 to 83   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 376/602
(62 %)
5 diff
(99.2 %id)
BE673109 Prostate .vb 4339 to 4702 364 to 1       364/364
(100 %)
0 diff
(100 %id)
AA541579 normal prostate, Prostate .vb 4365 to 4702 338 to 1       338/338
(100 %)
0 diff
(100 %id)
AW771956 Kidney .vb 4365 to 4700 339 to 4       336/339
(99 %)
0 diff
(100 %id)
BF939155 Prostate .vb 4365 to 4702 338 to 1       338/338
(100 %)
1 diff
(99.8 %id)
AW207460   .vb 4400 to 4702 320 to 18   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 303/303
(100 %)
0 diff
(100 %id)
AW366283 head_neck .vb 4493 to 4705 217 to 5       213/221
(96 %)
0 diff
(100 %id)
DB079069 testis .vc 1 to 557 2 to 558 C9R tiling clone, capped   557/557
(100 %)
1 diff
(99.9 %id)
DB461151 testis .vd 1 to 478 1 to 479 A3G Q22P S23N N24Q I25H ... tiling clone,   477/479
(99 %)
14 diff
(97.1 %id)
DB015732 esophageal, tumor tissue .ve 1 to 559 2 to 560   tiling clone, capped   559/559
(100 %)
1 diff
(99.9 %id)
BG176934 lymph, lymphoma, cell line .ve 348 to 868 1 to 538 V3F K4V M5R G6W W7A ... tiling clone,   538/700
(76 %)
27 diff
(96.2 %id)
CD643300 Embryonic Stem cells .ve 455 to 1118 6 to 669 exact     664/670
(99 %)
7 diff
(99.0 %id)
BQ649390 hepatocellular carcinoma, cell line, Liver .ve 488 to 1372 6 to 907 exact     902/908
(99 %)
30 diff
(96.7 %id)
BU839666 hepatocellular carcinoma, cell line, Liver .ve 496 to 1453 1 to 962 exact tiling clone,   962/962
(100 %)
17 diff
(98.3 %id)
BQ651044 hepatocellular carcinoma, cell line, Liver .ve 496 to 1400 1 to 915 exact     915/932
(98 %)
19 diff
(98.0 %id)
BQ646467 hepatocellular carcinoma, cell line, Liver .ve 496 to 1265 1 to 777 exact     777/965
(80 %)
21 diff
(97.9 %id)
BQ654349 hepatocellular carcinoma, cell line, Liver .ve 496 to 1326 1 to 836 exact     836/920
(90 %)
29 diff
(96.9 %id)
BG826901 muscle, rhabdomyosarcoma .ve 516 to 1254 1 to 746 S8*     746/746
(100 %)
21 diff
(97.2 %id)
CB215645 normal endometrium, late proliferativephase, cycle day 13, uterus .ve 534 to 1183 1 to 651 exact     651/651
(100 %)
1 diff
(99.9 %id)
BE295313 muscle, rhabdomyosarcoma .ve 536 to 1201 1 to 661 L13S G14V A15R K16R E17S ...     661/661
(100 %)
7 diff
(99.0 %id)
CX758692 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .ve 540 to 1245 1 to 706   tiling clone, Submitted on the opposite strand 706/706
(100 %)
0 diff
(100 %id)
BU948967.
matches multiple genes
Pancreas, Purified pancreatic islet .ve 613 to 1202 1 to 590     Submitted on the opposite strand, also hits gene PRSS1andTRY5andTRY6 590/590
(100 %)
1 diff
(99.9 %id)
BG033980 breast, mammary adenocarcinoma, cell line .ve 633 to 1428 1 to 784       784/957
(81 %)
19 diff
(98.1 %id)
BE276629 melanotic melanoma, skin .ve 661 to 1171 1 to 511       511/511
(100 %)
0 diff
(100 %id)
BE264482 lung, small cell carcinoma .ve 671 to 1349 1 to 673       673/718
(93 %)
9 diff
(98.8 %id)
Z43754 brain, total brain .ve 673 to 1023 1 to 351       351/351
(100 %)
2 diff
(99.5 %id)
BG403569 bladder, transitional cell papilloma, cell line .ve 679 to 1451 1 to 765       765/773
(98 %)
12 diff
(98.5 %id)
BQ678975 melanotic melanoma, cell line, skin .ve 679 to 1505 1 to 830   tiling clone,   830/831
(99 %)
9 diff
(99.0 %id)
BX106296 liver and spleen .ve 681 to 1418 1 to 738       738/738
(100 %)
0 diff
(100 %id)
BM685828 eye, Retina Foveal and Macular .ve 710 to 1322 1 to 612     Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 612/612
(100 %)
6 diff
(99.1 %id)
BE792874 lung, small cell carcinoma .ve 717 to 1355 1 to 638       638/638
(100 %)
1 diff
(99.9 %id)
BU726197 eye, Retina Foveal and Macular .ve 1485 to 2006 539 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 522/522
(100 %)
3 diff
(99.5 %id)
BU948717.
matches multiple genes
Pancreas, Purified pancreatic islet .ve 1554 to 2006 464 to 12   AAA Submitted on the opposite strand, also hits gene PRSS1andTRY5andTRY6 453/453
(100 %)
1 diff
(99.8 %id)
Z39812 brain, total brain .ve 1683 to 2012 330 to 1   tiling clone,   330/330
(100 %)
0 diff
(100 %id)
AW073205 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma .vf 1 to 431 433 to 1 T31A I34V K51E C61R tiling clone,   433/433
(100 %)
14 diff
(96.8 %id)
CD252407 White Matter .vg 1 to 656 678 to 23   tiling clone, Submitted on the opposite strand 656/954
(68 %)
0 diff
(100 %id)
CU446643 epidermis .vg 309 to 758 482 to 33     Submitted on the opposite strand 450/493
(91 %)
1 diff
(99.8 %id)
EL593348 epidermis, skin .vg 309 to 823 530 to 16 D54N L55R tiling clone, Submitted on the opposite strand 515/547
(94 %)
0 diff
(100 %id)
AW803186 uterus .vh-u 1 to 387 1 to 387 exact tiling clone,   387/387
(100 %)
6 diff
(98.5 %id)
BU957036 adenocarcinoma, cell line, breast .vh-u 167 to 632 1 to 466   tiling clone,   466/965
(48 %)
4 diff
(99.6 %id)
DA575682   .vi 1 to 546 7 to 552 exact tiling clone, capped   551/551
(100 %)
0 diff
(100 %id)
AI907058 breast .vj-u 1 to 538 80 to 617 exact tiling clone,   538/633
(84 %)
12 diff
(98.2 %id)
AA553533 Schwannoma tumor .vk-u 1 to 368 385 to 19 G18A P19R H21T I22S N23T ... tiling clone,   367/385
(95 %)
0 diff
(100 %id)
BF850740 lung_normal .vk-u 124 to 454 17 to 344   tiling clone,   328/345
(95 %)
6 diff
(98.3 %id)
BF799551 colon_ins .vk-u 131 to 457 344 to 16     Submitted on the opposite strand 329/364
(90 %)
0 diff
(100 %id)
BF869848 lung_tumor .vk-u 141 to 454 1 to 314       314/315
(99 %)
17 diff
(94.7 %id)
BF872082 lung_tumor .vk-u 141 to 448 1 to 308       308/308
(100 %)
1 diff
(99.7 %id)
171 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u, .i, .j, .k, .l, .m, .n, .o, .p-u, .q, .r, .s, .t, .u, .va-u, .vb, .vc, .vd, .ve, .vf, .vg, .vh-u, .vi, .vj-u, .vk-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI